KPWHRI is leading the National Institute of Allergy and Infectious Diseases-sponsored phase 1 trial testing mRNA vaccine.
Upon retirement, MacColl Center co-founder Brian Austin reflects on how the Center became a global pioneer in health care transformation.
But for most women, digital breast tomosynthesis improves cancer detection and reduces recalls, writes Dr. Yates Coley.
In JAMA, Kaiser Permanente and PCORI experts outline principles for applying genomic data to community health.
Dr. Eric B. Larson, a report contributor, answers questions about reducing risks, disparities, and threats from COVID-19.
Having long tracked infectious diseases and tested vaccines for safety and effectiveness, KPWHRI now focuses on the novel coronavirus.
Please send comments or suggestions to Communications Director Joan DeClaire at Joan.M.Declaire@kp.org.